4//SEC Filing
Czuczman Myron 4
Accession 0001213900-22-062472
CIK 0001506251other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:05 PM ET
Size
8.8 KB
Accession
0001213900-22-062472
Insider Transaction Report
Form 4
Czuczman Myron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Purchase Common Stock)
2022-10-04+300,000→ 300,000 totalExercise: $1.25Exp: 2032-10-04→ Common Stock (300,000 underlying)
Holdings
- 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (300,000 underlying) - 500,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.19Exp: 2030-07-14→ Common Stock (500,000 underlying)
Footnotes (3)
- [F1]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F2]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F3]One-third of the shares of the Company's common stock underlying the grant vest on the one-year anniversary of the Vesting Commencement Date, July 14, 2020, with the remainder vesting in 24 equal monthly installments thereafter, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001817716
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:05 PM ET
- Size
- 8.8 KB